Investigating Halloysite Nanotubes as a Potential Platform for Oral Modified Delivery of Different BCS Class Drugs: Characterization, Optimization, and Evaluation of Drug Release Kinetics

• Published in: International journal of nanomedicine Vol. 16; pp. 1725 - 1741
• Main Authors: Husain, Tazeen, Shoaib, Muhammad Harris, Ahmed, Farrukh Rafiq, Yousuf, Rabia Ismail, Farooqi, Sadaf, Siddiqui, Fahad, Imtiaz, Muhammad Suleman, Maboos, Madiha, Jabeen, Sabahat
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2021; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Administration, Oral; Aluminum Silicates - chemistry; Atenolol; Biopharmaceutics - classification; biopharmaceutics classification system; Clay; Clay - chemistry; Design of experiments; Drug Delivery Systems; Drug dosages; Drug Liberation; drug release kinetics; dta; Flurbiprofen; Football (College); ftir; Furosemide; halloysite nanotubes (hnt); Investigations; Kinetics; Nanotubes; Nanotubes - chemistry; Optimization; Original Research; Pharmaceutical Preparations - administration & dosage; Polymers; Scanning electron microscopy; sem; Solvents; Spectroscopy, Fourier Transform Infrared; Spectrum analysis; Variables; verapamil hcl; X-Ray Diffraction; xrd; Japan; New Zealand; Pakistan; Germany; DTA; drug release kinetics; flurbiprofen; FTIR; atenolol; biopharmaceutics classification system; furosemide; SEM; XRD; verapamil HCl; halloysite nanotubes; HNT
• ISSN: 1178-2013; 1176-9114; 1178-2013
• DOI: 10.2147/IJN.S299261

This study systematically investigated the potential of four model drugs (verapamil HCl, flurbiprofen, atenolol, and furosemide), each belonging to a different class of Biopharmaceutics Classification Systems (BCS) to be developed into oral modified release dosage forms after loading with halloysite nanotubes (HNTs). The drugs were studied for their loading (mass gain %) by varying solvent system, method, pH, and ratios of loading into the nanotubes using D-optimal split-plot design with the help of Design Expert software. Drug-loaded halloysites were characterized by XRD, DTA, FTIR, SEM, and HPLC-UV-based assay procedures. Dissolution studies were also performed in dissolution media with pH 1.2, 4.5, and 6.8. Moreover, the optimized samples were evaluated under stress stability conditions for determining prospects for the development of oral dosage forms. As confirmed with the results of XRD and DTA, the drugs were found to be converted into amorphous form after loading with halloysite (HNTs). The drugs were loaded in the range of ~7-9% for the four drugs, with agitation providing satisfactory and equivalent loading as compared to vacuum plus agitation based reported methods. FTIR results revealed either only weak electrostatic (verapamil HCl and flurbiprofen) or no interaction with the surface structure of the HNTs. The dissolution profiling depicted significantly retarded release of drugs with Fickian diffusion from a polydisperse system as a model that suits well for the development of oral dosage forms. HPLC-UV-based assay indicated that except furosemide (BCS class IV), the other three drugs are quite suitable for development for oral dosage forms. The four drugs investigated undergo phase transformation with HNTs. While agitation is an optimum method for loading drugs with various physicochemical attributes into HNTs; solvent system, loading ratios and pH play an important role in the loading efficiency respective to the drug properties. The study supports the capability of developing HNT-based modified release oral dosage forms for drugs with high solubility.